Literature DB >> 31314656

Ultrabiomicroscopic Findings in Acute Uveitic, Convalescent and Chronic Recurrent Stage of Vogt-Koyanagi-Harada Syndrome.

Diana Isabel Pachón-Suárez1,2, Mariana Mayorquín Ruiz3, Luz Elena Concha-Del-Río1, Rashel Cheja-Kalb1, Eduardo Moragrega3, Lourdes Arellanes-García1.   

Abstract

PURPOSE: To describe the ultrabiomicroscopy (UBM) characteristics in patients with uveitic, convalescent, and recurrent Vogt-Koyanagi-Harada (VKH) disease.
METHODS: In this prospective, non-interventional, and observational study, all UBM variables, namely pars plicata and pars plana thickness, ciliochoroidal detachment, angle chamber, anterior chamber depth, ID2, and presence of ciliary processes, were compared between acute uveitic, convalescent, and chronic-recurrent phases.
RESULTS: Ninety-one eyes were analyzed. Ciliochoroidal detachment (20%) and unclear ciliary processes (15%) are the most characteristic findings of the uveitic phase. At 1 and 3 months, ciliochoroidal detachment is no longer observed. In recurrent phase, pars plicata and pars plana thickness increases again and then decreases after the first month of treatment. Convalescent-phase does not show significant differences in UBM variables after a 6-month follow up.
CONCLUSIONS: UBM may have a role in evaluating response to treatment in uveitic and recurrent phases and in the early detection of recurrences.

Entities:  

Keywords:  Anterior chamber angle; UBM; VKH; pars plana; pars plicata

Mesh:

Year:  2019        PMID: 31314656     DOI: 10.1080/09273948.2019.1609527

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  1 in total

Review 1.  Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease.

Authors:  Cristhian A Urzua; Carl Herbort; Rodrigo A Valenzuela; Ahmed M Abu El-Asrar; Lourdes Arellanes-Garcia; Ariel Schlaen; Joyce Yamamoto; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.